Halbert Hargrove Global Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.15K | Buy |
+3
| New | +$1.03K | ﹤0.01% | 429 |
|
|
2025
Q4 | – | Sell |
-39
| Closed | -$11K | – | 384 |
|
|
2025
Q3 | $11K | Buy |
+39
| New | +$11.3K | ﹤0.01% | 317 |
|
|
2025
Q2 | – | Sell |
-33
| Closed | -$10.2K | – | 331 |
|
|
2025
Q1 | $10.2K | Buy |
+33
| New | +$9.74K | ﹤0.01% | 245 |
|
|
2023
Q2 | – | Sell |
-1,254
| Closed | -$303K | – | 101 |
|
|
2023
Q1 | $303K | Sell |
1,254
-21
| -2% | -$5.16K | 0.02% | 110 |
|
|
2022
Q4 | $335K | Buy |
1,275
+67
| +6% | +$18K | 0.02% | 98 |
|
|
2022
Q3 | $272K | Buy |
1,208
+56
| +5% | +$13.6K | 0.02% | 117 |
|
|
2022
Q2 | $280K | Buy |
1,152
+33
| +3% | +$8.09K | 0.02% | 117 |
|
|
2022
Q1 | $271K | Buy |
1,119
+38
| +4% | +$8.73K | 0.02% | 130 |
|
|
2021
Q4 | $243K | Sell |
1,081
-79
| -7% | -$16.7K | 0.02% | 138 |
|
|
2021
Q3 | $247K | Sell |
1,160
-309
| -21% | -$71.1K | 0.02% | 122 |
|
|
2021
Q2 | $358K | Buy |
1,469
+314
| +27% | +$77.2K | 0.02% | 91 |
|
|
2021
Q1 | $287K | Buy |
1,155
+29
| +3% | +$6.92K | 0.02% | 94 |
|
|
2020
Q4 | $259K | Buy |
1,126
+3
| +0.3% | +$692 | 0.02% | 92 |
|
|
2020
Q3 | $285K | Buy |
1,123
+31
| +3% | +$7.68K | 0.03% | 73 |
|
|
2020
Q2 | $258K | Sell |
1,092
-53
| -5% | -$12.1K | 0.04% | 72 |
|
|
2020
Q1 | $232K | Buy |
1,145
+33
| +3% | +$7.21K | 0.04% | 66 |
|
|
2019
Q4 | $268K | Sell |
1,112
-65
| -6% | -$14.3K | 0.07% | 61 |
|
|
2019
Q3 | $228K | Buy |
1,177
+77
| +7% | +$14.8K | 0.06% | 72 |
|
|
2019
Q2 | $203K | Sell |
1,100
-4
| -0.4% | -$716 | 0.06% | 77 |
|
|
2019
Q1 | $210K | Sell |
1,104
-9
| -0.8% | -$1.72K | 0.74% | 41 |
|
|
2018
Q4 | $217K | Buy |
1,113
+3
| +0.3% | +$585 | 0.05% | 69 |
|
|
2018
Q3 | $230K | Sell |
1,110
-51
| -4% | -$10.1K | 0.06% | 68 |
|
|
2018
Q2 | $214K | Sell |
1,161
-12
| -1% | -$2.12K | 0.06% | 67 |
|
|
2018
Q1 | $200K | Buy |
+1,173
| New | +$215K | 0.05% | 71 |
|
|
2017
Q4 | – | Sell |
-1,099
| Closed | -$205K | – | 72 |
|
|
2017
Q3 | $205K | Buy |
+1,099
| New | +$195K | 0.06% | 63 |
|
|
2016
Q4 | – | Sell |
-1,337
| Closed | -$223K | – | 75 |
|
|
2016
Q3 | $223K | Sell |
1,337
-162
| -11% | -$27.4K | 0.06% | 61 |
|
|
2016
Q2 | $228K | Buy |
1,499
+52
| +4% | +$8.09K | 0.07% | 64 |
|
|
2016
Q1 | $217K | Sell |
1,447
-234
| -14% | -$34.8K | 0.08% | 70 |
|
|
2015
Q4 | $273K | Sell |
1,681
-74
| -4% | -$11.6K | 0.12% | 71 |
|
|
2015
Q3 | $243K | Sell |
1,755
-1,831
| -51% | -$289K | 0.12% | 76 |
|
|
2015
Q2 | $551K | Sell |
3,586
-160
| -4% | -$25.6K | 0.13% | 70 |
|
|
2015
Q1 | $599K | Buy |
3,746
+1,562
| +72% | +$246K | 0.19% | 67 |
|
|
2014
Q4 | $348K | Buy |
2,184
+10
| +0.5% | +$1.56K | 0.17% | 67 |
|
|
2014
Q3 | $305K | Buy |
+2,174
| New | +$284K | 0.08% | 95 |
|
|
2014
Q2 | – | Sell |
-3,670
| Closed | -$453K | – | 122 |
|
|
2014
Q1 | $453K | Sell |
3,670
-198
| -5% | -$24K | 0.14% | 48 |
|
|
2013
Q4 | $441K | Sell |
3,868
-81
| -2% | -$9.21K | 0.14% | 50 |
|
|
2013
Q3 | $442K | Buy |
3,949
+6
| +0.2% | +$651 | 0.15% | 48 |
|
|
2013
Q2 | $389K | Buy |
+3,943
| New | +$409K | 0.14% | 55 |
|
Other funds holding AMGN
Halbert Hargrove Global Advisors's AMGN Position: Q2 2026 in Review
Halbert Hargrove Global Advisors opened a new position in Amgen (AMGN) in Q2 2026: 3 shares worth $1.15K. The stake represents ﹤0.01% of the portfolio and ranks #429 among its holdings. This is a return to the name: Halbert Hargrove Global Advisors previously reported a position in AMGN as recently as Q3 2025.
Halbert Hargrove Global Advisors first reported a position in AMGN in Q2 2013 and has held it in 38 quarters since. The position peaked at $599K in Q1 2015. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Halbert Hargrove Global Advisors held 3 shares of Amgen worth $1.15K as of Q2 2026.
- Amgen was a new Halbert Hargrove Global Advisors position in Q2 2026.
- Amgen made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #429 holding.
- Halbert Hargrove Global Advisors first reported a position in Amgen in Q2 2013 and has held it in 38 quarters since.
- Halbert Hargrove Global Advisors's Amgen position peaked at $599K in Q1 2015.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.